AstraZeneca - Toprol-XL - Ownership and Business Overview

Healthcare ServicesCompany

AstraZeneca - Toprol-XL Ownership

Who owns AstraZeneca - Toprol-XL?

AstraZeneca - Toprol-XL is owned by Aralez Pharmaceuticals. It was acquired on October 4, 2016.

AstraZeneca - Toprol-XL Business Overview

Where is AstraZeneca - Toprol-XL headquartered?

AstraZeneca - Toprol-XL is headquartered in London, United Kingdom.

What sector is AstraZeneca - Toprol-XL in?

AstraZeneca - Toprol-XL is a healthcare services company.

Healthcare Services M&A Summary in 2016

Out of 60 sectors in the Mergr database, healthcare services ranked 5 in number of deals in 2016. The largest healthcare services acquisition in 2016 was Alere - which was acquired by Abbott Laboratories for $5.8B.

Join Mergr to view all 376 acquisitions of healthcare services companies in 2016, including 69 acquisitions by private equity firms, and 307 by strategics.

AstraZeneca Plc - Toprol-XL

London, W2 6BD
United Kingdom,

AstraZeneca Plc - Toprol-XL is a provider of treatment of high blood pressure. By lowering blood pressure, Toprol-XL may lower the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. Toprol-XL is also indicated for the long-term treatment of angina pectoris, to reduce angina attacks and to improve exercise tolerance and for the treatment of stable, symptomatic (NYHA Class II or III) heart failure of ischemic, hypertensive, or cardiomyopathic origin. It was studied in patients already receiving ACE inhibitors, diuretics, and, in the majority of cases, digitalis. In this population, Toprol-XL decreased the rate of mortality plus hospitalization, largely through a reduction in cardiovascular mortality and hospitalizations for heart failure.


 Subscribe to unlock this and 203,188
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 195K M&A Transactions
  • 199K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for AstraZeneca - Toprol-XL

Healthcare Services Companies , United Kingdom Companies